Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/197433
Management of progressive pulmonary fibrosis associated with connective tissue disease
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Introduction: Fibrotic interstitial lung disease (ILD) is a frequent and severe complication of connective tissue disease (CTD). Areas covered: In this narrative review, we update the most relevant differential characteristics of fibrotic ILD associated with CTD (CTD-ILD) and propose a diagnostic and therapeutic approach based on a review of the articles published between 2002 and 2022 through PubMed. Expert opinion: The subset of ILD, mainly the radiological/histological pattern and the degree of fibrotic component, usually determines the prognosis and therapeutic strategy for these patients. Some patients with CTD-ILD can develop progressive pulmonary fibrosis (PPF) with severe deterioration of lung function, rapid progression to chronic respiratory failure, and high mortality. PPF has been described in many CTDs, mainly in systemic sclerosis and rheumatoid arthritis, and requires a multidisciplinary diagnostic and therapeutic approach to improve patient outcomes.
Subject (English)
Citation
Citation
MOLINA MOLINA, María, et al. Management of progressive pulmonary fibrosis associated with connective tissue disease. Expert Review Of Respiratory Medicine. 2022. Vol. 16, num. 7, pags. 765-774. ISSN 1747-6348. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/197433